Posts With Tag intranasal foralumab

Tiziana Life Sciences' 6-K report reveals highlights from a news feature on foralumab, showcasing patient experiences in Alzheimer's treatment and enhancing public awareness of innovative therapies.

Tiziana Life Sciences LTD announces a review on intranasal foralumab for neurodegenerative diseases, published in Nature Reviews Neurology. Key insights and implications for investors.

Discover Tiziana Life Sciences' latest Form 6-K report detailing a major milestone in Alzheimer's research with intranasal foralumab. Key insights and implications for investors.